Biofabrication and optimization of silver nanoparticles using Campsis sp. to explore their antimicrobial properties

Plant mediated green synthesis of silver nanoparticles (AgNPs) holds promising applications in the field of Biomedicine, Food packaging and Wound healing. In the present investigation, biofabrication of AgNPs was performed using the aqueous extracts of Campsis sp. (Family Bignoniaceae) leaves and flowers growing in the premises of Kirori Mal College, University of Delhi, Delhi. Optimization of AgNPs was performed to analyse the varying effect of pH (6.0, 8.0, 10.0) and silver salt concentration (2mM, 4Mm and 6Mm) in controlling the shape and size of AgNPs which in turn governs their further applications. Interestingly, change in colour of the reaction mixture from pale yellow to reddish brown indicated the formation of AgNPs. These AgNPs were further characterized by UV-Visible spectroscopy and showed peak in the range of 400-450 nm which confirmed the synthesis of silver nanoparticles. Dynamic light scattering and zeta potential analysis (DLS-Zeta) confirmed the size of AgNPs around 200-300 nm. A significant zone of inhibition was observed for both Staphylococcus aureus (gram-positive) and Escherichia coli (gram-negative) bacterial strains which revealed the antimicrobial potential of Campsis sp. AgNPs. Therefore, Campsis AgNPs may provide a green, eco-sustainable alternate method for sustainable production of nanomaterials for biomedical applications. These AgNPs may also show tremendous applications in food packaging, wound healing and biomedical fields.

Biofabricated nanoparticles: Their delivery and utility in Plutella xylostella management

The diamondback moth (DBM), Plutella xylostella (L.) (Lepidoptera: Plutellidae) is one of the most serious cosmopolitan pests of cruciferous plants. It causes severe damage to crop quality and production, with estimated global losses of 20-40% per year. Consumer preference regarding pest-free and uncontaminated crop, unavailability of highly competitive natural enemies as well as migratory nature of DBM has obligated for the mandatory use of insecticides. The over reliance and indiscriminate use of chemical insecticides to control DBM has lead to development of resistance against almost all the modern insecticides. In addition, it has also developed resistance against most of the Bt strain. To overcome the problem of resistance, there is an urgent need for new and highly efficient method to control DBM which must be eco-friendly, cost effective and has minimum impact on the environment. One of such alternatives is nanotechnology which fulfil all the criteria to become an ideal insecticide or delivery system for insect pest management especially DBM. Nanotechnology offers great improvement in the field of pesticides as it is less toxic, shelf-life enhancement and higher water solubility. Loading of Indoxacarb on nanoparticles are reported to be highly effective they suppressed the activity of detoxification enzymes such as GST, CarE, and P450. Green synthesis of AgNPs, Single walled carbon nano tube (SWCNT) also exhibits larvicidal and pupicidal effect. These are also reported to adversely affect food consumption, growth, pupation and fecundity of P. xylostella.These nanoparticles have been found to be more stable, also the controlled release of active ingredient for a long time and provides target specific control of P. xylostella for solving adverse situations ofthe crop fields like less food security, lesser food productivity and environmental imbalance.

Green Reactants Act As Natural Precursor For Facile Synthesis Of Nanoparticles Using Withania Somnifera

Nanotechnology includes physical and chemical approaches intended for their phytofabrication of metal nanoparticles. Most of the time, these methods are not as safe as these are associated with the utilization of extremely noxious and hazardous substances that produce biological problems. Due to their manifold applications, various biological methods are gaining admiration for the fabrication of silver nanoparticles (AgNPs). The utilization of vegetative parts in the biosynthesis of nanoparticles (NPs) emerges as a commercial and ecological approach. The spectroscopic profile confirms the occurrence of a functional peak at 360 nm. Fourier transform infrared spectroscopy (FTIR) studies indicate that phenol groups are responsible for phytofabrication of NPs. The results of microbicidal screening confirm that broad spectrum of inhibition was found to be observed in 400 μL of biosynthesized AgNP against E. coli (23 mm) and B. cereus (22.3 mm) Therefore, the progress of simple photosynthesis methods avoid deleterious and harmful properties has fascinated major attention in this field.

Hybrid Additive Microfabrication Scaffold Incorporated with Highly Aligned Nanofibers for Musculoskeletal Tissues

BACKGROUND: Latest tissue engineering strategies for musculoskeletal tissues regeneration focus on creating a biomimetic microenvironment closely resembling the natural topology of extracellular matrix. This paper presents a novel musculoskeletal tissue scaffold fabricated by hybrid additive manufacturing method. METHODS: The skeleton of the scaffold was 3D printed by fused deposition modeling, and a layer of random or aligned polycaprolactone nanofibers were embedded between two frames. A parametric study was performed to investigate the effects of process parameters on nanofiber morphology. A compression test was performed to study the mechanical properties of the scaffold. Human fibroblast cells were cultured in the scaffold for 7 days to evaluate the effect of scaffold microstructure on cell growth. RESULTS: The tip-to-collector distance showed a positive correlation with the fiber alignment, and the electrospinning time showed a negative correlation with the fiber density. With reinforced nanofibers, the hybrid scaffold demonstrated superior compression strength compared to conventional 3D-printed scaffold. The hybrid scaffold with aligned nanofibers led to higher cell attachment and proliferation rates, and a directional cell organization. In addition, there was a nonlinear relationship between the fiber diameter/density and the cell actinfilament density. CONCLUSION: This hybrid biofabrication process can be established as a highly efficient and scalable platform to fabricate biomimetic scaffolds with patterned fibrous microstructure, and will facilitate future development of clinical solutions for musculoskeletal tissue regeneration.

Bioimpressão e produção de mini-órgãos com células tronco / Bioprinting with stem cells and production of mini-organs

A bioimpressão é considerada uma fonte promissora no desenvolvimento celular, e na produção de mini-órgãos, válulas, cartilagens que futuramente poderão ser utilizados na terapia para transplantes em animais e humanos. Assim, essa técnica poderá ser utilizada como uma terapia eletiva, no tratamento de injúrias e principalmente no tratamento de doenças crônico-degenerativas. Em humanos essa terapia está sendo pesquisada a fim de auxiliar a medicina no tratamento e regeneração de tecidos impressos a partir de arcabouços de células desenvolvidas a partir de células-tronco, biomateriais e impressões em 3D. O uso dessa tecnologia é também um auxiliar nas pesquisas oncológicas com o intuito de projetar e avaliar a proliferação celular de tumores, bem como a ação de novos medicamentos quimioterápicos. No entanto, a maior limitação para o uso da terapia utilizando-se a impressora de células, órgãos e tecidos em 3D é a falta de protocolos unificados com metodologias reprodutíveis e detalhadas; com o objetivo de viabilizar a utilização da impressora e a impressão de células, órgãos e tecidos em 3D. Dessa forma, esta revisão busca reunir as publicações mais atuais na área, as quais destacam os avanços no uso de bioimpressão com células-tronco, a fim de descrever as principais técnicas e os potenciais de utilização como alternativa terapêutica na medicina humana e veterinária.(AU)

The bioprinting is considered a promising source in cell development, and production of mini-organs, valves, cartilage that may eventually be used in therapy for transplantation in animals and humans. It can also be used as an elective therapy in the treatment of injuries and treatment of chronic degenerative diseases. In humans, this therapy is been studied mainly in the treatment and regeneration of tissues printed from scaffold cells developed from stem cells, biomaterials and impressions in 3D. This technology is also an aid for the study of the formation of tumors, in order to design and evaluate the cellular proliferation of the tumors and the action of new chemotherapy drugs. However, the main drawback to this therapy is the lack of standardized protocols with reproducible and detailed methodologies with the aim of enabling the use of bioprinting and printing cells, tissues and organs in 3D. Thus, this review seeks to bring together the most current publications of the bioprinting area in order to describe the technique and its potential use as a therapeutic alternative.(AU)